Abstract:【Objective】 To evaluate the role and relation of stromal cell-derived factor 1α(SDF-1α) and Bevacizumab(Avastin) in angiogenesis.【Methods】 For the capillary-like formation assay,an in vitro angiogenesis assay kit comprising co-cultures of human umbilical vascular endothelial cells(HUVECs) and human fibroblasts was used according to the manufacturer's instructions.Briefly,HUVECs and fibroblasts were co-cultured in 24-well plates with basal medium only(control) or basal medium containing various concentrations of recombinant human SDF-1α(10 ng/mL,100 ng/mL,1 000 ng/mL) and/or recombinant human VEGF165(10 ng/mL) and/or Bevacizumab(10 μg/mL) and/or anti-SDF-1α antibody(10 μg/mL).HUVECs and fibroblasts were co-cultured for a total of 11 days.The cells were then fixed and stained.The total length of the capillary structures per group was measured.DNA synthesis measured by 5′-bromo-2′-deoxyuridine(BrdU) incorporation was performed as an index of cell proliferation.HUVECs were stimulated with various concentrations of recombinant human SDF-1α(10 ng/mL,100 ng/mL, 1 000 ng/mL) and/or recombinant human VEGF165(100 ng/mL) and/or Bevacizumab(100 μg/mL) and/or anti-SDF-1α antibody(10 μg/mL) for 12 hours.After the stimulation,BrdU ELISA chemiluminescence was analyzed according to the manufacturer's protocol.【Results】 SDF-1α significantly enhanced capillary-like formation and HUVECs proliferation.The activation of capillary-like formation by VEGF165(10 ng/mL) was effectively inhibited by Bevacizumab(10 μg/mL)(P 0.01).However,capillary-like formation promoted by SDF-1α was not inhibited by Bevacizumab.SDF-1α significantly enhanced capillary-like formation with Bevacizumab(P 0.05).The promotion of HUVECs proliferation by VEGF165(100 ng/mL) was significantly inhibited by Bevacizumab(100 μg/mL)(P 0.05).However,HUVECs proliferation promoted by SDF-1α was not inhibited by Bevacizumab.SDF-1α significantly enhanced HUVECs proliferation with Bevacizumab(P 0.05).【Conclusions】 These results indicate that SDF-1α may play an important role in enhancement of angiogenesis in vitro.The promotion of angiogenesis by SDF-1α is not inhibited by Bevacizumab.

Role of SDF-1α and Bevacizumab in angiogenesis